GlassScriptPhysician profile
William J Meis
NPI 1831124015
$1,331.14
in general payments reported to CMS, 2019-2025
11 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $44.65 · 2021: $21.39 · 2022: $406 · 2023: $103 · 2024: $76.51 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $609.92 | 2021-2025 | Collagenase Santyl, Allevyn Life L 15.4x15.4 Ctn10, Grafix Pl |
| Organogenesis INC. | $386.64 | 2019-2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $65.67 | 2022 | |
| Kerecis Limited | $62.51 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lifenet Health | $47.30 | 2023-2024 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $47.28 | 2019-2025 | Nuzyra |
| Lemaitre Vascular, INC. | $32.89 | 2023 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Bioventus LLC | $27.39 | 2022 | |
| Kci USA, INC. | $24.60 | 2019 | |
| Urgo Medical North America, LLC | $16.22 | 2025 | Urgoclean Ag |
| Cashflow Solutions, LLC | $10.72 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Meis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.